Mumbai: CarePal Money, India’s integrated healthcare lending marketplace and a subsidiary of the CarePal Group, has crossed an annualised disbursement run rate of Rs. 150 crore, marking a 50 per cent increase from the ₹100 crore milestone it achieved just a few months ago.
According to the company, the growth has been driven by rising demand for structured healthcare financing and its expanding footprint across hospitals and patient segments in India.
“It offers one of the highest approval rates in the industry, larger average ticket sizes, and the ability to finance complex, high-cost treatments that are often overlooked by traditional non-banking financial companies (NBFCs),” the company said in a statement.
Piyush Jain, Co-Founder and CEO, CarePal Group, said, “Reaching Rs. 150 crore in annualised disbursements is a strong validation of the model we have built—one that works for patients, hospitals, and lenders alike. In India, over 40 per cent of healthcare costs are still paid out of pocket. With rising medical inflation, financing is no longer optional; it is essential. We remain committed to our goal of scaling to more than Rs. 2,000 crore in annual disbursements over the next five years.”
Sahil Lakshmanan, CEO, CarePal Money, said, “This milestone reflects the trust that patients and hospitals have placed in us. Our zero per cent interest model removes one of the biggest barriers to care cost. Patients receive timely treatment, hospitals improve retention and reduce revenue leakage, and lenders gain access to a high-quality, underserved borrower segment.”
